Edward Danielevich Virus

The purpose of the study. To search for and analyze literature data on the role of key players in steroidogenesis in the hormonal response to training and competitive stress, characterized by the capacity of the endocrine system to synthesize steroids under these conditions, with the subsequent aim of establishing an objective control of adaptive capacity and preservation of long-term athletic performance in qualified athletes. Methodology and organization of the study. A narrative literature review was conduct, including the search and analysis of relevant publications on the use of steroidogenesis participants as potential markers of athletes’ functional status, using the electronic scientific databases PubMed and eLibrary. Research results and conclusion. Under intense physical and psycho-emotional stress in the work of professional athletes, activation of the hypothalamic-pituitary-adrenal system is triggered as an integral component of adaptation mechanisms. It seems possible to consider changes in the concentrations of key players of steroidogenesis as potential biomarkers of adaptation to training loads as a reaction related to the individual physical potentials of athletes, to resistance to stress and to training. At the same time, intermediate hormones with lower concentrations and their role in athlete adaptation remain insufficiently studied. Given the low concentrations of steroidogenesis components, the use of chromatographic-mass spectrometric methods appear appropriate for their sensitive and selective determination in complex biological matrices.

Aim of the study: To study the quantitative dynamics of the myocardial damage marker troponin T (cTnT) in elite biathlonists as a response to the cyclic training aids used at the stages of the early season during the annual training cycle.Methods: The study involved 23 biathlonists undergoing centralized training as members of the national team of the Russian Federation. Serum cTnT quantitation was performed by means of electrochemiluminescent assay using Elecsys Troponin T hs reagent kit (Roche Diagnostics, Germany).Results: The mean group cTnT blood level in biathlonists did not exceed the upper limit of cardiac marker reference range established for healthy men (< 14 pg/ml). cTnT concentration of at the general preliminary stage was significantly higher than at the special preliminary stage (p < 0.05), whereas statistically significant differences between the special preliminary and precompetition stages were not found (p > 0.05). The maximum cTnT levels in the group of athletes were recorded in May and June, in July its concentration decreased at the trend level (p > 0.05), then from August to October a significant decrease was documented (p < 0.05).Conclusion: The low ALT and AST tissue specificity does nor reliably reveal functional myocardial overload as the response to physical exertion. In order to stratify the risk athletes with abnormal blood cTnT levels are recommended to diagnose the cardiovascular system within the in-depth biomedical observation, since it cannot be excluded that repeated bouts of endurance exercise, each causing subclinical effects, may have a cumulative effect on cardiac structure or function.

Despite the existing knowledge regarding the metabolic dysregulation of sulfur-containing amino acids in athletes during intense physical exercise, the precise role of S-adenosylmethionine and S-adenosylhomocysteine as biomarkers for adaptive changes remains unresolved. The challenge in addressing this issue lies in the substantial impact of matrix effects on quantitative outcomes under electrospray ionization conditions. To overcome this issue, we propose the adoption of a surrogate matrix for constructing calibration curves. In our study, a surrogate matrix was prepared by incubating pooled plasma from volunteers for 120 h at 37°C. By utilizing external calibration with a surrogate matrix and the standard addition method, we achieved a maximum concentration variation of 4 ng mL^–1 for the determination of both S-adenosylmethionine and S-adenosylhomocysteine.

We examined standard clinical and laboratory biochemical parameters, as well as the levels of aminothiols in the blood and urine (homocysteine (Hcy), cysteine (Cys), S-adenosylmethionine (SAM), and S-adenosylhomocysteine (SAH)) via capillary electrophoresis in patients with CKD at stages II–V. Patient outcomes were assessed after five years. To complete forecasting, correlation and ROC analysis were performed. It was found that the levels of Cys and Hcy in blood plasma were earlier markers of CKD starting from stage II, while the levels of SAM and SAM/SAH in urine made it possible to differentiate between CKD at stages II and III. Blood plasma Hcy and urinary SAM and SAM/SAH correlated with mortality, but plasma Hcy concentrations were more significant. Thus, plasma Hcy, urine SAM, and SAM/SAH can be considered to be potential diagnostic and prognostic markers in patients with CKD.

The very high intensity of exercise accompanied by mental stress triggers adaptive mechanisms associated with adrenocortical steroidogenesis. However, the association between adrenocortical steroidogenesis and the high intensity of exercise in elite athletes is poorly studied. A significant obstacle to solving this complex task is the wide range (4–5 orders) of steroid concentrations in serum and limitations related to the amount of biological samples taken from professional athletes. To solve this task, we have developed and validated a non-trivial approach for targeted serum metabolic profiling based on the use of LC-MS/MS with dual-polarity electrospray ionization. The developed method based on the proposed approach allows for the quantitative determination of 14 stress resistance biomarkers in elite athletes using a small amount of specimen within 8.5 min.

Platinum nanoparticles (nPts) have neuroprotective/antioxidant properties, but the mechanisms of their action in cerebrovascular disease remain unclear. We investigated the brain bioavailability of nPts and their effects on brain damage, cerebral blood flow (CBF), and development of brain and systemic oxidative stress (OS) in a model of cerebral ischemia (hemorrhage + temporary bilateral common carotid artery occlusion, tBCAO) in rats. The nPts (0.04 g/L, 3 ± 1 nm diameter) were administered to rats (N = 19) intraperitoneally at the start of blood reperfusion. Measurement of CBF via laser Doppler flowmetry revealed that the nPts caused a rapid attenuation of postischemic hypoperfusion. The nPts attenuated the apoptosis of hippocampal neurons, the decrease in reduced aminothiols level in plasma, and the glutathione redox status in the brain, which were induced by tBCAO. The content of Pt in the brain was extremely low (≤1 ng/g). Thus, nPts, despite the extremely low brain bioavailability, can attenuate the development of brain OS, CBF dysregulation, and neuronal apoptosis. This may indicate that the neuroprotective effects of nPts are due to indirect mechanisms rather than direct activity in the brain tissue. Research on such mechanisms may offer a promising trend in the treatment of acute disorders of CBF.

It was found that ischemic stroke (IS) results in decreased levels of a number of reduced forms of low molecular weight aminothiols (LMWTs). The study was aimed to assess the impact of type 2 diabetes mellitus (Т2D) on the total content, reduced forms and redox status of LMWTs in patients with IS. A total of 175 patients with IS in the internal carotid artery basin (the average age was 62 (55–69)) years) were assessed, who were admitted to the Center within the first 10–24 h since the onset of neurological disorder. The index group included 68 patients with IS and T2D (males made up 41.2%). The comparison group consisted of 107 patients with IS and stress hyperglycemia (males made up 57%), and the control group included 31 non-diabetic patients with chronic cerebrovascular disease (CCVD) (males made up 54.8%). The admission plasma levels of LMWTs were assessed by liquid chromatography in all patients. It was found, that IS in patients with T2D was associated with the rapid decrease in total cysteine (tCys), total glutathione (tGSH), total homocysteine (tHcy), reduced glutathione (rGSH), and glutathione redox status (GSH RS), along with the increase in cysteine redox status (Cys RS) and homocysteine redox status (Hcy RS). In contrast to patients with stress hyperglycemia developing during the acute period of IS, patients with T2D had lower tCys, tGSH, and tHcy levels. Thus, GSH RS of 4.06% or lower in the first 24 hours after the IS in patients with T2D was a predictor of poor functional outcome (mRS score was 3 or more 3 weeks after IS).

Acute brain ischemia is accompanied by a disruption of low-molecular-weight aminothiols (LMWTs) homeostasis, such as homocysteine (Hcy), cysteine (Cys), and glutathione (GSH). We investigated the r...

Electron ionization (EI) and chemical ionization (CI) mass spectra of methylphosphonic acid phosphates and phosphonates (surrogates of respective chemical war agents) and silyl derivatives and its O-alkyl esters (markers of hydrolysis products of chemical war agents) were investigated and respective limits of detection were determined by GC/MS (EI) and GC/MS (CI) in a single ion monitoring mode. Atmospheric pressure photo- and photochemical ionization (APPI/APPCI) mass spectra of the same compounds were investigated by GC/MS (APPI/APPCI) and conditions providing the registration of mass spectra consisting of only one peak, corresponding to the M⁺ or [M + H]⁺ ion, were chosen and the limits of detection in the single ion monitoring mode were determined. In addition, the limits of detection for all of the studied compounds by GC with a flameless thermionic detector (FTID) were determined. The limits of detection for phosphates and phosphonates by GC/MS (EI) (MS/MS), GC/MS (CI), GC/MS (APPI), and GC/MS (APPCI) and in the single ion monitoring mode were 0.2–1.0 pg, 1.0–6.0 pg, 10–30 pg, and 0.1–0.3 pg, respectively. For methylphosphonic acid silyl derivatives and its O-alkyl esters, the respective limits of detection were 0.2–4.0 pg, 1.0–5.0 pg, 10–25 pg, and 1.0–3.0 pg. The limits of detection for all the studied compounds by GC with FTID were 0.3–0.4 pg. This means that the rapid screening of the samples to be investigated should be based on the last named method and GC/MS must be used only for the selected samples.

Ischemic stroke (IS) and type 2 diabetes mellitus are factors that affect the homeostasis of low-molecularweight aminothiols (cysteine, homocysteine, glutathione etc.). It has already been shown that IS in the acute period led to a decrease a level of reduced forms of aminothiols, but it is not clear whether type 2 diabetes mellitus has a noticeable effect there. Objective: to reveal the features of homeostasis of aminothiols in patients with type 2 diabetes mellitus in acute IS. Material and methods. The study involved 76 patients with primary middle cerebral artery IS in the first 10–24 hours after development of neurological symptoms. Group 1 included 15 patients with IS and type 2 diabetes mellitus, group 2 — 61 patients with IS and stress hyperglycemia. Their total plasma levels of cysteine, homocysteine, and glutathione, their reduced forms, and redox status were determined at admission (in the first 24 hours after IS). Results. There was a decrease in the level of total glutathione level (1.27 vs. 1.65 μM, p = 0.021), as well as its reduced form (0.03 vs. 0.04 μM, p = 0.007) in patients with IS and type 2 diabetes mellitus. Patients with type 2 diabetes mellitus who had a low redox status of homocysteine (0.65–1.2%) and glutathione (0.7–2.0%) were also characterized by a decrease in total glutathione level (p = 0.02; p = 0.03). Conclusion. Thus, type 2 diabetes mellitus is associated with a decrease in the level of total glutathione in acute IS. Probably, type 2 diabetes mellitus is characterized by a particular relationship between the metabolism of homocysteine, glutathione and glucose. Therefore, the search for homocysteine-dependent approaches to correct glutathione metabolism in type 2 diabetes mellitus may be of interest as an adjuvant therapy for IS.